The Washington Times
  • Subscribe
  • Times News Services
  • RSS
  • Mobile Headlines
  • e-edition
  • E-MAIL ALERTS
  • REGISTER
  • LOG IN
  • E-MAIL ALERTS
  • WELCOME
  • Your Profile
  • Log Out
  • Front Page Image
  • Classifieds
  • Autos
  • Real Estate
  • Jobs
  • Special Sections
  • Customer Service
  • Home
  • News
  • Opinion
  • Sports
    • NFL
    • NBA/WNBA
    • MLB
    • NHL
    • Tennis
    • Golf
    • Motorsports
    • Soccer
    • NCAA
    • Olympics
    • Outdoors
    • Other
  • Culture
    • Home & Living
    • Family & Kids
    • Fashion
    • Food
    • Travel
    • Health
    • Washington Visitors
    • Books
    • Military History
    • Life
    • Auto
    • TV Listings
    • Movie Listings
    • Death Notices
    • Entertainment
  • Themes
  • Communities
  • Marketplace
    • Autos
    • Jobs
    • Real Estate
    • Classifieds
    • Shopping
    • Dining Out
    • Education
    • TWT Store
  • Videos
    • Two Guys
    • Birnbaum on Washington
    • Liz Glover
    • Amanda Carpenter
    • Morning Briefing
    • Documentaries
    • Joe Giganti
    • Video Game Minute
  • Podcasts
    • About Headlines
    • Audio and Radio
    • America's Morning News
  • NFL

    Same old problems plague Redskins

  • Politics

    Obama: It's Senate's turn on health care

  • Security

    Army chief wary of backlash against Muslim soldiers

  • Sports

    Offense erupts in Caps' victory

  • National

    KUHNHENN: 10% jobless rate is Obama's troubling world

  • World

    Joint forces probe NATO air strike

  • National

    Fla. shooting suspect 'mentally ill'

Home » News » Editor Favorites

Tuesday, June 17, 2008

VA testing drugs on war veterans

Rate this story

Average 0.00
after 0 votes
Login or register to rate this story

Experiments raise ethical questions

  • Font Size -+
  • Print
  • Email
  • Comment
  • Tweet this!
  • Share
  • Article
  • Comments ()
  • Click-2-Listen
  • Videos
Please stand by, images loading!
  • ROD LAMKEY JR./THE WASHINGTON TIMES
Veteran James Elliott arrives at the Veterans Affairs Medical Center in Washington for his scheduled substance-abuse class in April. Mr. Elliott, a chain smoker, served 15 months in Iraq as an Army sharpshooter and suffers post-traumatic stress disorder.
  • Iraq war veteran James Elliott opted for a government clinical trial for a smoking-cessation drug for $30 a month, starting in November. Two weeks later, the FDA informed the VA of serious side effects. (Rod Lamkey Jr./The Washington Times)
  • ROD LAMKEY JR./THE WASHINGTON TIMES
STILL SMOKING: Iraq war veteran James Elliott smokes on his porch in Silver Spring as he talks about his experiences in war and dealing with post-traumatic stress disorder. Mr. Elliott suffered a psychotic episode while taking the anti-smoking drug Chantix.

More Editor Favorites Stories

  • Same old problems plague Redskins
  • Obama: It's Senate's turn on health care
  • Army chief wary of backlash against Muslim soldiers
  • Offense erupts in Caps' victory

By Audrey Hudson

UPDATE: Obama's office sent a letter Tuesday to James Peake, secretary of the Department of Veterans Affairs, on the issue. You can read the full text of the letter here.

UPDATE II: Sen. John Cornyn, Texas Republican, issued his own letter to Peake as well. You can read it here.

The government is testing drugs with severe side effects like psychosis and suicidal behavior on hundreds of military veterans, using small cash payments to attract patients into medical experiments that often target distressed soldiers returning from Iraq and Afghanistan, a Washington Times/ABC News investigation has found.

In one such experiment involving the controversial anti-smoking drug Chantix, the Department of Veterans Affairs (VA) took three months to alert its patients about severe mental side effects. The warning did not arrive until after one of the veterans taking the drug had suffered a psychotic episode that ended in a near lethal confrontation with police.

James Elliott, a decorated Army sharpshooter who suffers from post-traumatic stress disorder (PTSD) after serving 15 months in Iraq, was confused and psychotic when he was Tasered by police in February as he reached for a concealed handgun when officers responded to a 911 call at his Maryland home.

For photos, video of James Elliott, official FDA documents and more, visit the interactive site for theDisposable Heroes report.

Mr. Elliott, a chain smoker, began taking Chantix last fall as part of a VA experiment that specifically targeted veterans with PTSD, opting to collect $30 a month for enrolling in the clinical trial because he needed cash as he returned to school. He soon began suffering hallucinations and suicidal thoughts, unaware that the new drug he was taking could have caused them.

Just two weeks after Mr. Elliott began taking Chantix in November, the VA learned from the Food and Drug Administration (FDA) that the drug was linked to a large number of hallucinations, suicide attempts and psychotic behavior. But the VA did not alert Mr. Elliott before his own episode in February.

In failing to do so, Mr. Elliott said, the VA treated him like a "disposable hero."

"You're a lab rat for $30 a month," Mr. Elliott said.

[Get Copyright Permissions] Click here for reprint permissions!
Copyright 2009 The Washington Times, LLC

12345678Next »

Post a comment

There are comments on this article, submit your opinion!

Please login or register to post a comment

Ask a Question

You Report

Do you have another point of view, photos, audio, video or more information about a story?

Top Stories

Most Read

  1. EXCLUSIVE: Rare virus poses new threat to troops
  2. Sniper's ex-wife speaks out on abuse
  3. Parents buying homes for kids at college
  4. PRUDEN: Corpse sits up, gets nice salute
  5. Inside the Beltway
More Top Stories »
  1. Armored troop carriers called unsafe for duty
  2. EDITORIAL: Too scared to recognize terrorism
  3. 13 killed at Texas army base; psychiatrist accused
  4. House OKs health reform bill
  5. Aborted fetus cells used in beauty creams

Most Shared

  1. Parents buying homes for kids at college
  2. EXCLUSIVE: Rare virus poses new threat to troops
  3. EDITORIAL: Too scared to recognize terrorism
  4. Sunshine vitamin stirs new debate
  5. Looking to 2010, GOP focuses on fiscal restraint
More Top Stories »
  1. Aborted fetus cells used in beauty creams
  2. Israelis unsure of U.S. support
  3. EDITORIAL: The negative Obama factor
  4. Obama's unlearned lesson
  5. EDITORIAL: Obama has a 'Pet Goat' moment

Most Commented

  1. House OKs health reform bill
  2. EDITORIAL: Too scared to recognize terrorism
  3. Muslims stunned by Fort Hood shooting
  4. Furious scramble for health reform support
  5. 'Gentle' Army psychiatrist displayed worrisome signs
More Top Stories »
  1. Obama praises those who ended Fort Hood violence
  2. EXCLUSIVE: Rare virus poses new threat to troops
  3. Making fun of faith
  4. Israelis unsure of U.S. support
  5. Army chief wary of backlash against Muslim soldiers

Listen to Washington Times Radio

  • America's Morning News

    with John McCaslin and Melanie Morgan

Question of the day

White House officials and Senate Democrats met in private three times last week to craft health care legislation. Do you think these discussions should be more public?

Blogs & Columns

  • POTUS Notes

    New Dem talking point on Obama approval doesn't wash

  • The Back Story

    12 arrested at Pelosi's office

  • Belief Blog

    Washington goes Greek this week

  • Out of Context

    Foods that might kill libido

  • Technology

    Facebook wins round against phishing spammer

  • On the Fly

    United lifts some 'award' blocking

  • Redskins 360

    Samuels feeling better, hopeful

  • Tara's Two Cents

    On their way to summer vacation..

  • SNOBlog

    Beyond 'Woody'

Videos

Advertising Links
TWT Store
  • e-edition
  • Print Edition
  • Weekly Washington Times
TWT Affiliates
  • Middle East Times
  • Golf
  • UPI
  • Arbor Ballroom
  • Washington Times Global
  • About TWT
  • Press Room
  • F.A.Q.
  • Work for TWT
  • Advertise
  • Sponsors
  • Contact Us
  • Privacy Policy
  • Site Map

All site contents © Copyright 2009 The Washington Times, LLC.